nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Anagrelide—hematologic cancer	0.0369	0.0583	CbGbCtD
Gemfibrozil—CYP2C9—Bexarotene—hematologic cancer	0.023	0.0364	CbGbCtD
Gemfibrozil—SLCO1B1—Irinotecan—hematologic cancer	0.0219	0.0346	CbGbCtD
Gemfibrozil—CYP2C8—Bortezomib—hematologic cancer	0.0203	0.032	CbGbCtD
Gemfibrozil—CYP1A2—Carmustine—hematologic cancer	0.0194	0.0306	CbGbCtD
Gemfibrozil—CYP2C9—Idarubicin—hematologic cancer	0.0191	0.0302	CbGbCtD
Gemfibrozil—CYP2C19—Bortezomib—hematologic cancer	0.017	0.0268	CbGbCtD
Gemfibrozil—CYP1A2—Methoxsalen—hematologic cancer	0.0165	0.026	CbGbCtD
Gemfibrozil—CYP1A2—Bortezomib—hematologic cancer	0.0157	0.0248	CbGbCtD
Gemfibrozil—CYP2C8—Ifosfamide—hematologic cancer	0.0155	0.0245	CbGbCtD
Gemfibrozil—CYP1A2—Daunorubicin—hematologic cancer	0.015	0.0237	CbGbCtD
Gemfibrozil—CYP2C19—Thalidomide—hematologic cancer	0.0148	0.0234	CbGbCtD
Gemfibrozil—CYP1A2—Alitretinoin—hematologic cancer	0.0147	0.0232	CbGbCtD
Gemfibrozil—CYP2C9—Bortezomib—hematologic cancer	0.0141	0.0223	CbGbCtD
Gemfibrozil—CYP2C19—Teniposide—hematologic cancer	0.0141	0.0223	CbGbCtD
Gemfibrozil—CYP1A2—Thalidomide—hematologic cancer	0.0137	0.0216	CbGbCtD
Gemfibrozil—CYP2C8—Nilotinib—hematologic cancer	0.0135	0.0213	CbGbCtD
Gemfibrozil—CYP3A4—Bexarotene—hematologic cancer	0.0134	0.0212	CbGbCtD
Gemfibrozil—CYP2C19—Ifosfamide—hematologic cancer	0.013	0.0206	CbGbCtD
Gemfibrozil—CYP3A4—Lomustine—hematologic cancer	0.0125	0.0197	CbGbCtD
Gemfibrozil—CYP3A4—Busulfan—hematologic cancer	0.0125	0.0197	CbGbCtD
Gemfibrozil—CYP2C19—Imatinib—hematologic cancer	0.0124	0.0197	CbGbCtD
Gemfibrozil—CYP2C9—Thalidomide—hematologic cancer	0.0123	0.0194	CbGbCtD
Gemfibrozil—CYP1A2—Dacarbazine—hematologic cancer	0.0117	0.0186	CbGbCtD
Gemfibrozil—CYP2C9—Teniposide—hematologic cancer	0.0117	0.0185	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—hematologic cancer	0.0116	0.0183	CbGbCtD
Gemfibrozil—CYP1A2—Imatinib—hematologic cancer	0.0115	0.0181	CbGbCtD
Gemfibrozil—CYP3A4—Thiotepa—hematologic cancer	0.0111	0.0175	CbGbCtD
Gemfibrozil—CYP2C9—Ifosfamide—hematologic cancer	0.0108	0.0171	CbGbCtD
Gemfibrozil—CYP2C9—Imatinib—hematologic cancer	0.0104	0.0163	CbGbCtD
Gemfibrozil—CYP2C9—Nilotinib—hematologic cancer	0.00941	0.0149	CbGbCtD
Gemfibrozil—CYP1A2—Dasatinib—hematologic cancer	0.00923	0.0146	CbGbCtD
Gemfibrozil—CYP3A4—Methoxsalen—hematologic cancer	0.00864	0.0136	CbGbCtD
Gemfibrozil—CYP3A4—Bortezomib—hematologic cancer	0.00821	0.013	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—hematologic cancer	0.0082	0.013	CbGbCtD
Gemfibrozil—CYP3A4—Daunorubicin—hematologic cancer	0.00786	0.0124	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—hematologic cancer	0.00742	0.0117	CbGbCtD
Gemfibrozil—CYP3A4—Cytarabine—hematologic cancer	0.00693	0.0109	CbGbCtD
Gemfibrozil—CYP3A4—Teniposide—hematologic cancer	0.00683	0.0108	CbGbCtD
Gemfibrozil—CYP3A4—Ifosfamide—hematologic cancer	0.0063	0.00995	CbGbCtD
Gemfibrozil—CYP2C8—Dexamethasone—hematologic cancer	0.0061	0.00964	CbGbCtD
Gemfibrozil—CYP3A4—Imatinib—hematologic cancer	0.00602	0.00951	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—hematologic cancer	0.00575	0.00908	CbGbCtD
Gemfibrozil—CYP3A4—Ruxolitinib—hematologic cancer	0.00567	0.00895	CbGbCtD
Gemfibrozil—CYP3A4—Nilotinib—hematologic cancer	0.00547	0.00864	CbGbCtD
Gemfibrozil—CYP3A4—Vinorelbine—hematologic cancer	0.00542	0.00857	CbGbCtD
Gemfibrozil—CYP2C9—Cisplatin—hematologic cancer	0.00527	0.00832	CbGbCtD
Gemfibrozil—CYP2C19—Dexamethasone—hematologic cancer	0.00512	0.00809	CbGbCtD
Gemfibrozil—CYP3A4—Triamcinolone—hematologic cancer	0.00496	0.00783	CbGbCtD
Gemfibrozil—CYP3A4—Dasatinib—hematologic cancer	0.00483	0.00763	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—hematologic cancer	0.00477	0.00754	CbGbCtD
Gemfibrozil—CYP2C9—Dexamethasone—hematologic cancer	0.00426	0.00672	CbGbCtD
Gemfibrozil—CYP3A4—Betamethasone—hematologic cancer	0.00426	0.00672	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—hematologic cancer	0.0042	0.00663	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—hematologic cancer	0.00397	0.00626	CbGbCtD
Gemfibrozil—CYP3A4—Irinotecan—hematologic cancer	0.00376	0.00594	CbGbCtD
Gemfibrozil—CYP3A4—Vinblastine—hematologic cancer	0.00334	0.00528	CbGbCtD
Gemfibrozil—CYP3A4—Vincristine—hematologic cancer	0.00329	0.00519	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—hematologic cancer	0.00301	0.00476	CbGbCtD
Gemfibrozil—CYP3A4—Dexamethasone—hematologic cancer	0.00248	0.00391	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—hematologic cancer	0.00205	0.00324	CbGbCtD
Gemfibrozil—PPARA—hematopoietic system—hematologic cancer	0.002	0.134	CbGeAlD
Gemfibrozil—PPARA—blood—hematologic cancer	0.00132	0.089	CbGeAlD
Gemfibrozil—SLCO1B1—hematopoietic system—hematologic cancer	0.00127	0.0856	CbGeAlD
Gemfibrozil—PPARA—lung—hematologic cancer	0.00116	0.078	CbGeAlD
Gemfibrozil—PPARA—testis—hematologic cancer	0.00109	0.0736	CbGeAlD
Gemfibrozil—SLCO1B1—blood—hematologic cancer	0.000844	0.0567	CbGeAlD
Gemfibrozil—CYP2C19—hematopoietic system—hematologic cancer	0.00083	0.0558	CbGeAlD
Gemfibrozil—PPARA—lymph node—hematologic cancer	0.000793	0.0534	CbGeAlD
Gemfibrozil—CYP2C8—hematopoietic system—hematologic cancer	0.000724	0.0487	CbGeAlD
Gemfibrozil—CYP1A2—hematopoietic system—hematologic cancer	0.000678	0.0456	CbGeAlD
Gemfibrozil—CYP2C9—hematopoietic system—hematologic cancer	0.000643	0.0433	CbGeAlD
Gemfibrozil—CYP2C19—blood—hematologic cancer	0.00055	0.037	CbGeAlD
Gemfibrozil—CYP3A4—hematopoietic system—hematologic cancer	0.00049	0.033	CbGeAlD
Gemfibrozil—CYP2C8—blood—hematologic cancer	0.00048	0.0323	CbGeAlD
Gemfibrozil—CYP1A2—blood—hematologic cancer	0.000449	0.0302	CbGeAlD
Gemfibrozil—CYP2C9—blood—hematologic cancer	0.000426	0.0287	CbGeAlD
Gemfibrozil—CYP2C8—testis—hematologic cancer	0.000397	0.0267	CbGeAlD
Gemfibrozil—CYP1A2—lung—hematologic cancer	0.000394	0.0265	CbGeAlD
Gemfibrozil—CYP3A4—blood—hematologic cancer	0.000325	0.0219	CbGeAlD
Gemfibrozil—Vomiting—Mitoxantrone—hematologic cancer	4.2e-05	0.000163	CcSEcCtD
Gemfibrozil—Vomiting—Irinotecan—hematologic cancer	4.2e-05	0.000163	CcSEcCtD
Gemfibrozil—Nausea—Alitretinoin—hematologic cancer	4.18e-05	0.000163	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—hematologic cancer	4.18e-05	0.000163	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—hematologic cancer	4.18e-05	0.000162	CcSEcCtD
Gemfibrozil—Rash—Mitoxantrone—hematologic cancer	4.17e-05	0.000162	CcSEcCtD
Gemfibrozil—Rash—Irinotecan—hematologic cancer	4.17e-05	0.000162	CcSEcCtD
Gemfibrozil—Dermatitis—Irinotecan—hematologic cancer	4.16e-05	0.000162	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—hematologic cancer	4.16e-05	0.000162	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—hematologic cancer	4.14e-05	0.000161	CcSEcCtD
Gemfibrozil—Headache—Irinotecan—hematologic cancer	4.14e-05	0.000161	CcSEcCtD
Gemfibrozil—Nausea—Ifosfamide—hematologic cancer	4.13e-05	0.000161	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.12e-05	0.00016	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.12e-05	0.00016	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—hematologic cancer	4.11e-05	0.00016	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—hematologic cancer	4.11e-05	0.00016	CcSEcCtD
Gemfibrozil—Feeling abnormal—Triamcinolone—hematologic cancer	4.11e-05	0.00016	CcSEcCtD
Gemfibrozil—Diarrhoea—Cisplatin—hematologic cancer	4.1e-05	0.00016	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—hematologic cancer	4.09e-05	0.000159	CcSEcCtD
Gemfibrozil—Vomiting—Gemcitabine—hematologic cancer	4.09e-05	0.000159	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.08e-05	0.000159	CcSEcCtD
Gemfibrozil—Paraesthesia—Betamethasone—hematologic cancer	4.06e-05	0.000158	CcSEcCtD
Gemfibrozil—Paraesthesia—Dexamethasone—hematologic cancer	4.06e-05	0.000158	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—hematologic cancer	4.06e-05	0.000158	CcSEcCtD
Gemfibrozil—Rash—Gemcitabine—hematologic cancer	4.06e-05	0.000158	CcSEcCtD
Gemfibrozil—Dermatitis—Gemcitabine—hematologic cancer	4.05e-05	0.000158	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—hematologic cancer	4.05e-05	0.000158	CcSEcCtD
Gemfibrozil—Headache—Gemcitabine—hematologic cancer	4.03e-05	0.000157	CcSEcCtD
Gemfibrozil—Nausea—Vincristine—hematologic cancer	4.03e-05	0.000157	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—hematologic cancer	4.02e-05	0.000157	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—hematologic cancer	3.99e-05	0.000155	CcSEcCtD
Gemfibrozil—Dyspepsia—Betamethasone—hematologic cancer	3.98e-05	0.000155	CcSEcCtD
Gemfibrozil—Dyspepsia—Dexamethasone—hematologic cancer	3.98e-05	0.000155	CcSEcCtD
Gemfibrozil—Urticaria—Triamcinolone—hematologic cancer	3.96e-05	0.000154	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—hematologic cancer	3.95e-05	0.000154	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—hematologic cancer	3.94e-05	0.000153	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—hematologic cancer	3.94e-05	0.000153	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—hematologic cancer	3.94e-05	0.000153	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—hematologic cancer	3.94e-05	0.000153	CcSEcCtD
Gemfibrozil—Nausea—Irinotecan—hematologic cancer	3.92e-05	0.000153	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—hematologic cancer	3.92e-05	0.000153	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—hematologic cancer	3.91e-05	0.000152	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.9e-05	0.000152	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.9e-05	0.000152	CcSEcCtD
Gemfibrozil—Fatigue—Betamethasone—hematologic cancer	3.9e-05	0.000152	CcSEcCtD
Gemfibrozil—Fatigue—Dexamethasone—hematologic cancer	3.9e-05	0.000152	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—hematologic cancer	3.89e-05	0.000151	CcSEcCtD
Gemfibrozil—Shock—Prednisone—hematologic cancer	3.87e-05	0.000151	CcSEcCtD
Gemfibrozil—Pain—Dexamethasone—hematologic cancer	3.87e-05	0.000151	CcSEcCtD
Gemfibrozil—Pain—Betamethasone—hematologic cancer	3.87e-05	0.000151	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—hematologic cancer	3.86e-05	0.00015	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—hematologic cancer	3.83e-05	0.000149	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—hematologic cancer	3.83e-05	0.000149	CcSEcCtD
Gemfibrozil—Nausea—Gemcitabine—hematologic cancer	3.82e-05	0.000149	CcSEcCtD
Gemfibrozil—Vomiting—Cisplatin—hematologic cancer	3.81e-05	0.000148	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—hematologic cancer	3.8e-05	0.000148	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—hematologic cancer	3.8e-05	0.000148	CcSEcCtD
Gemfibrozil—Rash—Cisplatin—hematologic cancer	3.78e-05	0.000147	CcSEcCtD
Gemfibrozil—Dermatitis—Cisplatin—hematologic cancer	3.78e-05	0.000147	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—hematologic cancer	3.76e-05	0.000146	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—hematologic cancer	3.75e-05	0.000146	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—hematologic cancer	3.73e-05	0.000145	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betamethasone—hematologic cancer	3.73e-05	0.000145	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dexamethasone—hematologic cancer	3.73e-05	0.000145	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—hematologic cancer	3.72e-05	0.000145	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Betamethasone—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—hematologic cancer	3.7e-05	0.000144	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—hematologic cancer	3.67e-05	0.000143	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—hematologic cancer	3.63e-05	0.000141	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—hematologic cancer	3.62e-05	0.000141	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—hematologic cancer	3.62e-05	0.000141	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—hematologic cancer	3.61e-05	0.00014	CcSEcCtD
Gemfibrozil—Urticaria—Dexamethasone—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Gemfibrozil—Urticaria—Betamethasone—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.59e-05	0.00014	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—hematologic cancer	3.58e-05	0.000139	CcSEcCtD
Gemfibrozil—Asthenia—Triamcinolone—hematologic cancer	3.58e-05	0.000139	CcSEcCtD
Gemfibrozil—Abdominal pain—Dexamethasone—hematologic cancer	3.57e-05	0.000139	CcSEcCtD
Gemfibrozil—Abdominal pain—Betamethasone—hematologic cancer	3.57e-05	0.000139	CcSEcCtD
Gemfibrozil—Nausea—Cisplatin—hematologic cancer	3.56e-05	0.000139	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—hematologic cancer	3.56e-05	0.000138	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—hematologic cancer	3.54e-05	0.000138	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—hematologic cancer	3.54e-05	0.000138	CcSEcCtD
Gemfibrozil—Pruritus—Triamcinolone—hematologic cancer	3.53e-05	0.000137	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—hematologic cancer	3.52e-05	0.000137	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—hematologic cancer	3.51e-05	0.000137	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—hematologic cancer	3.49e-05	0.000136	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—hematologic cancer	3.49e-05	0.000136	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—hematologic cancer	3.49e-05	0.000136	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—hematologic cancer	3.47e-05	0.000135	CcSEcCtD
Gemfibrozil—Rash—Etoposide—hematologic cancer	3.46e-05	0.000135	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—hematologic cancer	3.46e-05	0.000135	CcSEcCtD
Gemfibrozil—Headache—Etoposide—hematologic cancer	3.44e-05	0.000134	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—hematologic cancer	3.44e-05	0.000134	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—hematologic cancer	3.43e-05	0.000134	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—hematologic cancer	3.43e-05	0.000133	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—hematologic cancer	3.42e-05	0.000133	CcSEcCtD
Gemfibrozil—Rash—Prednisolone—hematologic cancer	3.42e-05	0.000133	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—hematologic cancer	3.41e-05	0.000133	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.41e-05	0.000133	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—hematologic cancer	3.39e-05	0.000132	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—hematologic cancer	3.39e-05	0.000132	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—hematologic cancer	3.38e-05	0.000132	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—hematologic cancer	3.38e-05	0.000131	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—hematologic cancer	3.37e-05	0.000131	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—hematologic cancer	3.32e-05	0.000129	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—hematologic cancer	3.32e-05	0.000129	CcSEcCtD
Gemfibrozil—Dizziness—Triamcinolone—hematologic cancer	3.3e-05	0.000128	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—hematologic cancer	3.29e-05	0.000128	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—hematologic cancer	3.29e-05	0.000128	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—hematologic cancer	3.29e-05	0.000128	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—hematologic cancer	3.27e-05	0.000127	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—hematologic cancer	3.26e-05	0.000127	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—hematologic cancer	3.25e-05	0.000126	CcSEcCtD
Gemfibrozil—Asthenia—Dexamethasone—hematologic cancer	3.24e-05	0.000126	CcSEcCtD
Gemfibrozil—Asthenia—Betamethasone—hematologic cancer	3.24e-05	0.000126	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—hematologic cancer	3.23e-05	0.000126	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—hematologic cancer	3.23e-05	0.000126	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—hematologic cancer	3.22e-05	0.000125	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—hematologic cancer	3.22e-05	0.000125	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—hematologic cancer	3.22e-05	0.000125	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—hematologic cancer	3.21e-05	0.000125	CcSEcCtD
Gemfibrozil—Pruritus—Betamethasone—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Gemfibrozil—Pruritus—Dexamethasone—hematologic cancer	3.2e-05	0.000125	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—hematologic cancer	3.2e-05	0.000124	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.19e-05	0.000124	CcSEcCtD
Gemfibrozil—Vomiting—Triamcinolone—hematologic cancer	3.17e-05	0.000123	CcSEcCtD
Gemfibrozil—Rash—Triamcinolone—hematologic cancer	3.14e-05	0.000122	CcSEcCtD
Gemfibrozil—Dermatitis—Triamcinolone—hematologic cancer	3.14e-05	0.000122	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—hematologic cancer	3.14e-05	0.000122	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—hematologic cancer	3.13e-05	0.000122	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—hematologic cancer	3.13e-05	0.000122	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—hematologic cancer	3.13e-05	0.000122	CcSEcCtD
Gemfibrozil—Headache—Triamcinolone—hematologic cancer	3.12e-05	0.000122	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—hematologic cancer	3.11e-05	0.000121	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—hematologic cancer	3.11e-05	0.000121	CcSEcCtD
Gemfibrozil—Diarrhoea—Dexamethasone—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Gemfibrozil—Diarrhoea—Betamethasone—hematologic cancer	3.09e-05	0.00012	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—hematologic cancer	3.08e-05	0.00012	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—hematologic cancer	3.08e-05	0.00012	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—hematologic cancer	3.07e-05	0.000119	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—hematologic cancer	3.05e-05	0.000119	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—hematologic cancer	3.03e-05	0.000118	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—hematologic cancer	3.03e-05	0.000118	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—hematologic cancer	3.02e-05	0.000118	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—hematologic cancer	3.02e-05	0.000117	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3e-05	0.000117	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—hematologic cancer	2.99e-05	0.000116	CcSEcCtD
Gemfibrozil—Dizziness—Dexamethasone—hematologic cancer	2.99e-05	0.000116	CcSEcCtD
Gemfibrozil—Dizziness—Betamethasone—hematologic cancer	2.99e-05	0.000116	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—hematologic cancer	2.97e-05	0.000116	CcSEcCtD
Gemfibrozil—Nausea—Triamcinolone—hematologic cancer	2.96e-05	0.000115	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—hematologic cancer	2.96e-05	0.000115	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.95e-05	0.000115	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—hematologic cancer	2.93e-05	0.000114	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—hematologic cancer	2.9e-05	0.000113	CcSEcCtD
Gemfibrozil—Vomiting—Betamethasone—hematologic cancer	2.88e-05	0.000112	CcSEcCtD
Gemfibrozil—Vomiting—Dexamethasone—hematologic cancer	2.88e-05	0.000112	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—hematologic cancer	2.87e-05	0.000112	CcSEcCtD
Gemfibrozil—Rash—Dexamethasone—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Rash—Betamethasone—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Dermatitis—Dexamethasone—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Dermatitis—Betamethasone—hematologic cancer	2.85e-05	0.000111	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.84e-05	0.000111	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—hematologic cancer	2.84e-05	0.00011	CcSEcCtD
Gemfibrozil—Headache—Dexamethasone—hematologic cancer	2.83e-05	0.00011	CcSEcCtD
Gemfibrozil—Headache—Betamethasone—hematologic cancer	2.83e-05	0.00011	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—hematologic cancer	2.83e-05	0.00011	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—hematologic cancer	2.81e-05	0.00011	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.81e-05	0.000109	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—hematologic cancer	2.8e-05	0.000109	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—hematologic cancer	2.79e-05	0.000109	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—hematologic cancer	2.79e-05	0.000109	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—hematologic cancer	2.79e-05	0.000108	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—hematologic cancer	2.77e-05	0.000108	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—hematologic cancer	2.77e-05	0.000108	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—hematologic cancer	2.74e-05	0.000107	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—hematologic cancer	2.71e-05	0.000106	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—hematologic cancer	2.71e-05	0.000106	CcSEcCtD
Gemfibrozil—Diarrhoea—Prednisone—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Gemfibrozil—Nausea—Betamethasone—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Gemfibrozil—Nausea—Dexamethasone—hematologic cancer	2.69e-05	0.000105	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.66e-05	0.000103	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—hematologic cancer	2.66e-05	0.000103	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—hematologic cancer	2.63e-05	0.000103	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—hematologic cancer	2.63e-05	0.000103	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—hematologic cancer	2.61e-05	0.000102	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—hematologic cancer	2.6e-05	0.000101	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—hematologic cancer	2.6e-05	0.000101	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.6e-05	0.000101	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—hematologic cancer	2.56e-05	9.96e-05	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—hematologic cancer	2.54e-05	9.88e-05	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—hematologic cancer	2.53e-05	9.86e-05	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—hematologic cancer	2.52e-05	9.8e-05	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—hematologic cancer	2.51e-05	9.76e-05	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—hematologic cancer	2.5e-05	9.75e-05	CcSEcCtD
Gemfibrozil—Rash—Prednisone—hematologic cancer	2.48e-05	9.66e-05	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—hematologic cancer	2.48e-05	9.66e-05	CcSEcCtD
Gemfibrozil—Headache—Prednisone—hematologic cancer	2.47e-05	9.6e-05	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.46e-05	9.58e-05	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—hematologic cancer	2.46e-05	9.56e-05	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—hematologic cancer	2.45e-05	9.52e-05	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—hematologic cancer	2.44e-05	9.49e-05	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—hematologic cancer	2.44e-05	9.49e-05	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—hematologic cancer	2.43e-05	9.48e-05	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—hematologic cancer	2.36e-05	9.19e-05	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—hematologic cancer	2.35e-05	9.14e-05	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—hematologic cancer	2.34e-05	9.1e-05	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.33e-05	9.07e-05	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—hematologic cancer	2.33e-05	9.06e-05	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—hematologic cancer	2.26e-05	8.81e-05	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—hematologic cancer	2.25e-05	8.77e-05	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—hematologic cancer	2.25e-05	8.76e-05	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—hematologic cancer	2.21e-05	8.6e-05	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—hematologic cancer	2.18e-05	8.48e-05	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—hematologic cancer	2.18e-05	8.47e-05	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—hematologic cancer	2.11e-05	8.2e-05	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—hematologic cancer	2.09e-05	8.14e-05	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—hematologic cancer	2.08e-05	8.08e-05	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—hematologic cancer	2.07e-05	8.07e-05	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—hematologic cancer	2.06e-05	8.02e-05	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—hematologic cancer	2.04e-05	7.96e-05	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—hematologic cancer	2.04e-05	7.93e-05	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—hematologic cancer	2.02e-05	7.85e-05	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—hematologic cancer	1.96e-05	7.62e-05	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—hematologic cancer	1.95e-05	7.61e-05	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—hematologic cancer	1.95e-05	7.59e-05	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—hematologic cancer	1.94e-05	7.56e-05	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—hematologic cancer	1.94e-05	7.55e-05	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—hematologic cancer	1.93e-05	7.51e-05	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—hematologic cancer	1.88e-05	7.33e-05	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—hematologic cancer	1.83e-05	7.12e-05	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—hematologic cancer	1.81e-05	7.05e-05	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—hematologic cancer	1.8e-05	6.99e-05	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—hematologic cancer	1.8e-05	6.99e-05	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—hematologic cancer	1.79e-05	6.95e-05	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—hematologic cancer	1.69e-05	6.59e-05	CcSEcCtD
Gemfibrozil—PPARA—Metabolism—PIK3CB—hematologic cancer	9.23e-06	9.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.2e-06	9.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NUP98—hematologic cancer	9.2e-06	9.68e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AGRN—hematologic cancer	9.19e-06	9.68e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PC—hematologic cancer	9.19e-06	9.67e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NCOR1—hematologic cancer	9.16e-06	9.64e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—hematologic cancer	9.16e-06	9.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—UGT1A1—hematologic cancer	8.94e-06	9.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADCY7—hematologic cancer	8.93e-06	9.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOA3—hematologic cancer	8.93e-06	9.4e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GBA—hematologic cancer	8.87e-06	9.34e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.87e-06	9.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NUP214—hematologic cancer	8.86e-06	9.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.77e-06	9.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—IDH1—hematologic cancer	8.77e-06	9.23e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MAPK3—hematologic cancer	8.77e-06	9.23e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMMR—hematologic cancer	8.71e-06	9.17e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—IDH2—hematologic cancer	8.71e-06	9.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.7e-06	9.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.7e-06	9.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCG2—hematologic cancer	8.68e-06	9.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTR—hematologic cancer	8.68e-06	9.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.67e-06	9.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TXN—hematologic cancer	8.67e-06	9.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.67e-06	9.13e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—hematologic cancer	8.53e-06	8.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ENO2—hematologic cancer	8.52e-06	8.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.48e-06	8.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.48e-06	8.92e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—hematologic cancer	8.26e-06	8.69e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.22e-06	8.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NUP98—hematologic cancer	8.21e-06	8.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.19e-06	8.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.15e-06	8.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.13e-06	8.56e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTAP—hematologic cancer	8.12e-06	8.54e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—hematologic cancer	8.09e-06	8.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SDC1—hematologic cancer	8.07e-06	8.5e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—hematologic cancer	7.98e-06	8.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA9—hematologic cancer	7.97e-06	8.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACP5—hematologic cancer	7.97e-06	8.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.97e-06	8.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.97e-06	8.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.93e-06	8.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.93e-06	8.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NUP214—hematologic cancer	7.91e-06	8.33e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.87e-06	8.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.83e-06	8.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.75e-06	8.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTR—hematologic cancer	7.75e-06	8.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.73e-06	8.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.71e-06	8.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.61e-06	8.01e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—EP300—hematologic cancer	7.61e-06	8.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ENO2—hematologic cancer	7.6e-06	8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—IDH1—hematologic cancer	7.49e-06	7.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NUP98—hematologic cancer	7.48e-06	7.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTO1—hematologic cancer	7.41e-06	7.8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TXN—hematologic cancer	7.41e-06	7.8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCC3—hematologic cancer	7.41e-06	7.8e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.37e-06	7.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.28e-06	7.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.27e-06	7.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.27e-06	7.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.26e-06	7.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.25e-06	7.63e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FHL2—hematologic cancer	7.23e-06	7.61e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NUP214—hematologic cancer	7.21e-06	7.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SDC1—hematologic cancer	7.21e-06	7.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.14e-06	7.52e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.13e-06	7.51e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AGRN—hematologic cancer	7.09e-06	7.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.07e-06	7.44e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTR—hematologic cancer	7.07e-06	7.44e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.97e-06	7.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO2—hematologic cancer	6.93e-06	7.3e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.88e-06	7.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NQO1—hematologic cancer	6.86e-06	7.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CD44—hematologic cancer	6.86e-06	7.23e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	6.8e-06	7.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.8e-06	7.15e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.78e-06	7.13e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.78e-06	7.13e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IDH2—hematologic cancer	6.72e-06	7.08e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMMR—hematologic cancer	6.72e-06	7.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.72e-06	7.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.72e-06	7.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.62e-06	6.97e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALOX5—hematologic cancer	6.6e-06	6.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SDC1—hematologic cancer	6.57e-06	6.92e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.5e-06	6.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYCS—hematologic cancer	6.5e-06	6.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.45e-06	6.79e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NUP98—hematologic cancer	6.4e-06	6.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.32e-06	6.66e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CREBBP—hematologic cancer	6.3e-06	6.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.28e-06	6.61e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.21e-06	6.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.21e-06	6.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.2e-06	6.52e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NUP214—hematologic cancer	6.17e-06	6.49e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA9—hematologic cancer	6.15e-06	6.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACP5—hematologic cancer	6.15e-06	6.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CD44—hematologic cancer	6.13e-06	6.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NQO1—hematologic cancer	6.13e-06	6.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.1e-06	6.42e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.07e-06	6.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.04e-06	6.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTR—hematologic cancer	6.04e-06	6.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6e-06	6.32e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	5.98e-06	6.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.93e-06	6.24e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO2—hematologic cancer	5.92e-06	6.23e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—hematologic cancer	5.91e-06	6.22e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—hematologic cancer	5.9e-06	6.21e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.81e-06	6.11e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYCS—hematologic cancer	5.8e-06	6.1e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IDH1—hematologic cancer	5.78e-06	6.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.76e-06	6.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.74e-06	6.05e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.73e-06	6.03e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.72e-06	6.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TXN—hematologic cancer	5.72e-06	6.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.72e-06	6.02e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.66e-06	5.95e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	5.64e-06	5.94e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—hematologic cancer	5.63e-06	5.92e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SDC1—hematologic cancer	5.62e-06	5.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.6e-06	5.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CD44—hematologic cancer	5.59e-06	5.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NQO1—hematologic cancer	5.59e-06	5.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.54e-06	5.83e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.47e-06	5.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.42e-06	5.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.38e-06	5.66e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.36e-06	5.65e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.29e-06	5.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYCS—hematologic cancer	5.29e-06	5.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.26e-06	5.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.26e-06	5.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.25e-06	5.53e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.23e-06	5.5e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.23e-06	5.5e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	5.21e-06	5.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.18e-06	5.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.11e-06	5.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.1e-06	5.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.06e-06	5.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.94e-06	5.2e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NUP98—hematologic cancer	4.94e-06	5.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.84e-06	5.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.79e-06	5.04e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.79e-06	5.04e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CD44—hematologic cancer	4.77e-06	5.03e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NQO1—hematologic cancer	4.77e-06	5.03e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NUP214—hematologic cancer	4.76e-06	5.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.73e-06	4.98e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.7e-06	4.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.7e-06	4.94e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.68e-06	4.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTR—hematologic cancer	4.66e-06	4.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.66e-06	4.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.66e-06	4.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.65e-06	4.89e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—hematologic cancer	4.6e-06	4.84e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO2—hematologic cancer	4.57e-06	4.81e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYCS—hematologic cancer	4.52e-06	4.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.51e-06	4.75e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—hematologic cancer	4.5e-06	4.74e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.49e-06	4.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.43e-06	4.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.41e-06	4.64e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SDC1—hematologic cancer	4.33e-06	4.56e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—hematologic cancer	4.29e-06	4.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.28e-06	4.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.28e-06	4.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.15e-06	4.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.1e-06	4.31e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.04e-06	4.25e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.98e-06	4.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.91e-06	4.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.85e-06	4.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.78e-06	3.98e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.77e-06	3.97e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CD44—hematologic cancer	3.68e-06	3.88e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NQO1—hematologic cancer	3.68e-06	3.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.66e-06	3.85e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.66e-06	3.85e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.66e-06	3.85e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.62e-06	3.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.49e-06	3.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYCS—hematologic cancer	3.49e-06	3.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.46e-06	3.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.43e-06	3.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—hematologic cancer	3.39e-06	3.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.34e-06	3.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.24e-06	3.41e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.23e-06	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.23e-06	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.18e-06	3.35e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	3.18e-06	3.34e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.07e-06	3.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.07e-06	3.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—hematologic cancer	3.03e-06	3.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.99e-06	3.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.95e-06	3.1e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.91e-06	3.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.89e-06	3.05e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.85e-06	3e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.82e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.82e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.8e-06	2.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—hematologic cancer	2.76e-06	2.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.72e-06	2.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.67e-06	2.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.64e-06	2.78e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—hematologic cancer	2.59e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—hematologic cancer	2.59e-06	2.72e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.52e-06	2.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.5e-06	2.63e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—hematologic cancer	2.47e-06	2.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.44e-06	2.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.39e-06	2.51e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—hematologic cancer	2.36e-06	2.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—hematologic cancer	2.31e-06	2.43e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.26e-06	2.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—hematologic cancer	2.2e-06	2.32e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—hematologic cancer	2.11e-06	2.22e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.1e-06	2.21e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.08e-06	2.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—hematologic cancer	2.01e-06	2.11e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.94e-06	2.05e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.84e-06	1.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.82e-06	1.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—hematologic cancer	1.82e-06	1.92e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—hematologic cancer	1.8e-06	1.89e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.74e-06	1.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—hematologic cancer	1.72e-06	1.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.63e-06	1.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.61e-06	1.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—hematologic cancer	1.49e-06	1.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—hematologic cancer	1.39e-06	1.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—hematologic cancer	1.33e-06	1.4e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—hematologic cancer	1.32e-06	1.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—hematologic cancer	1.21e-06	1.28e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—hematologic cancer	1.04e-06	1.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.8e-07	1.03e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—hematologic cancer	8e-07	8.42e-06	CbGpPWpGaD
